7 Articles On #Esbriet
1. Genentech’s PF Drug Esbriet Shown To Lower Mortality Rates in New Study
Read the article here:Â http://bit.ly/1URSd1G
2. Esbriet’s Promise and Potential as a PF Therapy
Read the article here:Â http://bit.ly/1kub6MJ
3. Phase III Trials Reveal That IPF Patients Treated Continually with ESBRIET for Long-term Have Reduced Risk of Death
Read the article here:Â http://bit.ly/1NuJban
4. ESBRIET Recommended By The American Thoracic Society for IPF Treatment
Read the article here:Â http://bit.ly/1Ote9N0
5. Pirfenidone (Esbriet) Shown Efficacious and Safe in Multiple Studies For IPF
Read the article here:Â http://bit.ly/1N9BIZj
6. ESBRIET Found To Be Safe in Patients with Interstitial Lung Disease Associated With Systemic Sclerosis
Read the article here:Â http://bit.ly/1RHdFsS
7. New Data on Genentech’s Esbriet for Idiopathic Pulmonary Fibrosis Presented at 2015 ATS Conference
Read the article here:Â http://bit.ly/1OWzE8w